2013
DOI: 10.3390/mi4020257
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Platform for Enzyme-Linked and Magnetic Particle-Based Immunoassay

Abstract: This article presents design and testing of a microfluidic platform for immunoassay. The method is based on sandwiched ELISA, whereby the primary antibody is immobilized on nitrocelluose and, subsequently, magnetic beads are used as a label to detect the analyte. The chip takes approximately 2 h and 15 min to complete the assay. A Hall Effect sensor using 0.35-μm BioMEMS TSMC technology (Taiwan Semiconductor Manufacturing Company Bio-Micro-Electro-Mechanical Systems) was fabricated to sense the magnetic field … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 21 publications
0
13
0
Order By: Relevance
“…The proposed design is comparable in complexity to other microfluidic test platforms such as the one proposed by Bhalla et al [ 30 ]. Their work demonstrated a two-step validation method for Adiponectin detection using ELISA.…”
Section: Resultsmentioning
confidence: 92%
“…The proposed design is comparable in complexity to other microfluidic test platforms such as the one proposed by Bhalla et al [ 30 ]. Their work demonstrated a two-step validation method for Adiponectin detection using ELISA.…”
Section: Resultsmentioning
confidence: 92%
“…The method is based on enzyme‐linked immunoassay, where the antibody is immobilized on nitrocellulose and magnetic beads to label the analyte. The chip takes 2 h 15 min to detect protein followed by fluorescence measurement [159]. Micromachined MNPs were also used as separators in microfluidic systems for magnetic particle‐based bioseparation.…”
Section: Applicationsmentioning
confidence: 99%
“…The development of magnetic particles functionalized with antibodies have been leveraged into automated detection platforms (Bhalla et al 2013; Lien et al 2011; Yun et al 2007). Through automation, standard tests can be rendered hands-free, and using microfluidic platforms less sample or reagents are consumed.…”
Section: Development Of Potential Alternative and Future Biosensors Umentioning
confidence: 99%